China Universal Asset Management Company’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Sell
8,190
-888
-10% -$193K 0.12% 133
2026
Q1
$1.53M Buy
9,078
+863
+11% +$149K 0.12% 136
2025
Q4
$1.5M Sell
8,215
-532
-6% -$74.3K 0.12% 144
2025
Q3
$1.06M Sell
8,747
-1,142
-12% -$129K 0.09% 175
2025
Q2
$1.03M Buy
9,889
+107
+1% +$11.3K 0.1% 162
2025
Q1
$1.14M Sell
9,782
-494
-5% -$56.3K 0.11% 170
2024
Q4
$869K Buy
10,276
+1,044
+11% +$96K 0.08% 177
2024
Q3
$830K Buy
9,232
+3,652
+65% +$319K 0.09% 155
2024
Q2
$449K Sell
5,580
-3,523
-39% -$261K 0.06% 155
2024
Q1
$726K Buy
9,103
+3,628
+66% +$305K 0.09% 148
2023
Q4
$436K Buy
5,475
+4,271
+355% +$286K 0.08% 152
2023
Q3
$84.1K Buy
1,204
+633
+111% +$47.3K 0.02% 206
2023
Q2
$41K Sell
571
-18
-3% -$1.33K 0.01% 209
2023
Q1
$36.3K Buy
589
+148
+34% +$9.72K 0.01% 176
2022
Q4
$34K Buy
441
+64
+17% +$3.83K 0.01% 150
2022
Q3
$17K Buy
+377
New +$18.8K 0.01% 163

Other funds holding AXSM

China Universal Asset Management Company's AXSM Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Axsome Therapeutics (AXSM) stake by 9.8% in Q2 2026, selling an estimated $193K and leaving 8,190 shares worth $2M. The position accounts for 0.12% of the portfolio, ranked #133.

China Universal Asset Management Company first reported a position in AXSM in Q3 2022 and has held it in 16 quarters since. 328 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • China Universal Asset Management Company held 8,190 shares of Axsome Therapeutics worth $2M as of Q2 2026.
  • China Universal Asset Management Company sold 888 Axsome Therapeutics shares in Q2 2026, an estimated $193K.
  • Axsome Therapeutics made up 0.12% of China Universal Asset Management Company's portfolio in Q2 2026, its #133 holding.
  • China Universal Asset Management Company first reported a position in Axsome Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • 328 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.